Serious side effects, including leg, foot, and other amputation, have been associated with a new class of diabetes drugs known as SGLT-2 inhibitors. Accordingly, the FDA has required black boxed warnings for amputation risks for glucose-controlling medications such as Invokana.
FDA Warns of Amputations Connected to Certain Diabetes Drugs
Topics: Health News, Amputation, FDA, Diabetes Drug, The Law Offices of Foster & Houston, Amputation Lawsuit, FANDHLAW, Ryan Foster, Foster & Houston, Diabetes Drug Lawsuit, Amputation Compensation, Amputation Law, Amputation Attorney, Amputation Lawyer, Leg Amputation, Leg Amputation Attorney, Leg Amputation Law, Leg Amputation Lawsuit, Foot Amputation, Foot Amputation Compensation, Foot Amputation Attorney, Foot Amputation Lawyer, Invokana Compensation, Invokana Attorney, Invokana Law, Invokana Lawyer, Invokana Lawsuit, Type 2 Diabetes Medication, Diabetes Medication, SGLT-2 Inhibitors, SGLT-2 Inhibitors Lawsuit, Leg Amputation Compensation, Leg Amputation Lawyer, Foot Amputation Law, Foot Amputation Lawsuit, Invokana, Type 2 Diabetes
Research Finds Risk of Heart Attack Higher in Pradaxa Users
A study published by CBS News finds Pradaxa users at a 33% higher risk of developing heart disease or heart attack when compared to warfarin users. An editorial accompanying this study notes this isn’t the first safety warning issued for the anti-clotting drug Pradaxa.
Topics: Health, Health News, Pradaxa, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Pradaxa Lawsuit, Ryan Foster, Foster & Houston, Pradaxa Lawyer, Pradaxa Attorney, Pradaxa Law, Stroke
How Accurate were Xarelto Clinical Trial Results? A CBS News Investigation
Xarelto is a blood thinning medication used to treat atrial fibrillation in people who are also at risk for stroke. However, multiple lawsuits have been filed against the manufacturer of Xarelto claiming the company withheld important safety information.
Topics: Health, Health News, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Xarelto, Xarelto Lawsuit
ABC News: Levaquin Labels Don’t Fully Explain Risks of Use
According to plaintiffs in a federal lawsuit filed in the District of Columbia, pharmaceutical giant Johnson & Johnson, the manufacturer of Levaquin, hid details about the drug’s adverse side effects.
Topics: Health, FDA, Fluoroquinolones, FLQ Lawsuit, Fluoroquinolones Lawsuit, Fluoroquinolone, Avelox, Levaquin Lawsuit, FLQ, Fluoroquinolone Lawsuit, Levaquin, The Law Offices of Foster & Houston, Ryan Foster, Foster & Houston, Medical Update, Avelox Lawsuit, Avelox Law, Levaquin Law, Levaquin Lawyer, Levaquin Attorney, Avelox Lawyer, Avelox Attorney
Pradaxa Can Increase Risk of Stroke, Bleeding, Hematomas, and More
The FDA has issued a medication guide about the risks associated with the blood-thinner medication Pradaxa. Side effects associated with the drug include uncontrollable bleeding, hematomas, stroke and death.
Topics: Health, Health News, Pradaxa, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Pradaxa Lawsuit, Ryan Foster, Foster & Houston, Pradaxa Lawyer, Pradaxa Attorney, Pradaxa Law, Stroke
Disabling Side Effects Linked to Levaquin and Avelox
Serious side effects, including aortic aneurysm and long-term nerve damage, have been associated with a class of antibiotics called fluoroquinolones. Accordingly, the FDA has strengthened label warnings for bacteria-fighting drugs such as Levaquin and Avelox.
Topics: Health, FDA, Fluoroquinolones, FLQ Lawsuit, Fluoroquinolones Lawsuit, Fluoroquinolone, Avelox, Levaquin Lawsuit, FLQ, Fluoroquinolone Lawsuit, Levaquin, The Law Offices of Foster & Houston, Ryan Foster, Foster & Houston, Medical Update, Avelox Lawsuit, Avelox Law, Levaquin Law, Levaquin Lawyer, Levaquin Attorney, Avelox Lawyer, Avelox Attorney
Increased Risk of Cleft Palate Associated with Zofran
Based on the data available today, Zofran use during pregnancy cannot be assumed to be safe, claims the National Center for Biotechnology Information. In fact, a case-control study suggested there was an increased risk of cleft palate associated with Zofran.
Topics: Health, Medical, Medical News, FDA, The Law Offices of Foster & Houston, FANDHLAW, Zofran Lawsuit, Zofran, Ryan Foster, Foster & Houston
Xarelto Can Increase Risk of Bleeding, Hematomas, Stroke and More
Topics: Health, Health News, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Xarelto, Xarelto Lawsuit
Harvard Health: Higher Bleeding Risk Associated with Pradaxa
A study covered in the Harvard Health Publications blog finds Pradaxa users have a higher bleeding risk compared to Warfarin users. In this post, Howard LeWine, M.D., discusses Pradaxa research and shares his professional opinion about blood-thinners.
Topics: Health, Health News, Pradaxa, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Pradaxa Lawsuit, Ryan Foster, Foster & Houston, Mechanical Heart Valves, Juliet Foster, Julie Foster, Harvard Health
FDA Warns of Possibly Permanent Nerve Damage from Fluoroquinolone Drugs
Topics: Health, FDA, Fluoroquinolones, FLQ Lawsuit, Fluoroquinolones Lawsuit, Fluoroquinolone, Avelox, Levaquin Lawsuit, FLQ, Fluoroquinolone Lawsuit, Levaquin, The Law Offices of Foster & Houston, Ryan Foster, Foster & Houston, Medical Update, Avelox Lawsuit, Juliet Foster, Julie Foster, peripheral neuropathy